en

PRODUCT DETAIL

XABOPLAX 15 mg + 20 mg filmom obalené tablety

Code 6905E
MA number 16/0021/24-S
Product Form: tbl flm 49x1(42x1x15 mg+7x1x20 mg) (blis.PVC/PE/PVdC/Al - jednotk.bal.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Mutual recognition procedure
MAH, country: Sandoz Pharmaceuticals d.d., Slovenia
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AF Direct factor Xa inhibitors
B01AF01 Rivaroxaban
Shelf life: 36
Container: blister Al/PVC/PE/PVDC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 15.02.2024
Validity: 15.02.2029
Dokument: Príručka pre predpisujúceho lekára_rivaroxabán_V1.pdf  
SPC: SPC_XABOPLAX 15 mg + 20 mg filmom obalené tablety_07.2024.pdf  
PIL: PIL_XABOPLAX 15 mg + 20 mg filmom obalené tablety_07.2024.pdf  
Safety feature Yes
Data update: 23.07.2024
eu-flag.png sk-flag.png